Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
Dawn Q. Chong(National Cancer Centre Singapore), Paula YP Lam(National University of Singapore)
Cited by 41